Skip to main content

Part of the book series: Annual Update in Intensive Care and Emergency Medicine ((AUICEM))

Abstract

Peripartum maternal death is a tragedy that claims lives of young women and leaves behind a devastated family. Postpartum hemorrhage (PPH) is the leading cause of maternal mortality worldwide, and it is all the more tragic as, among causes of maternal mortality, death from PPH appears preventable in many, if not most cases, at least in resource rich countries [1–3]. Management of PPH involves an interdisciplinary team of midwives, obstetricians, anesthetists and transfusion specialists. The scope of this review is to highlight current trends in epidemiology, medical treatment and the current controversy on transfusion protocols, blood component therapy or specific pharmacological interventions on the coagulation system.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Berg CJ, Harper MA, Atkinson SM et al (2005) Preventability of pregnancy-related deaths: results of a state-wide review. Obstet Gynecol 106:1228–1234

    Article  PubMed  Google Scholar 

  2. Lewis G (2007) The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer – 2003–2005. The seventh report on confidential enquiries into maternal deaths in the United Kingdom. Available at: http://www.publichealth.hscni.net/sites/default/files/Saving%20Mothers'%20Lives%202003-05%20.pdf. Accessed October 2012

  3. Knight M, Callaghan WM, Berg C et al (2009) Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 9:55

    Article  PubMed  Google Scholar 

  4. Thaler I, Manor D, Itskovitz J et al (1990) Changes in uterine blood flow during human pregnancy. Am J Obstet Gynecol 162:121–125

    PubMed  CAS  Google Scholar 

  5. Sloan NL, Durocher J, Aldrich T et al (2010) What measured blood loss tells us about postpartum bleeding: a systematic review. BJOG 117:788–800

    Article  PubMed  CAS  Google Scholar 

  6. Stafford I, Dildy GA, Clark SL et al (2008) Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol 199:519.e1–519.e7

    Article  Google Scholar 

  7. Gahres EE, Albert SN, Dodek SM (1962) Intrapartum blood loss measured with Cr 51-tagged erythrocytes. Obstet Gynecol 19:455–462

    PubMed  CAS  Google Scholar 

  8. Carroli G, Cuesta C, Abalos E et al (2008) Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 22:999–1012

    Article  PubMed  Google Scholar 

  9. Biguzzi E, Franchi F, Ambrogi F et al (2012) Risk factors for postpartum hemorrhage in a cohort of 6011 Italian women. Thromb Res 129:e1–e7

    Article  PubMed  CAS  Google Scholar 

  10. Clark SL, Hankins GDV (2012) Preventing maternal death: 10 clinical diamonds. Obstet Gynecol 119:360–364

    Article  PubMed  Google Scholar 

  11. Rudra A, Chatterjee S, Sengupta S et al (2010) Management of obstetric hemorrhage. Middle East J Anesthesiol 20:499–507

    PubMed  Google Scholar 

  12. Nielson EC, Varner MW, Scott JR (1991) The outcome of pregnancies complicated by bleeding during the second trimester. Surg Gynecol Obstet 173:371–374

    PubMed  CAS  Google Scholar 

  13. Justus Hofmeyr G, Say L, Metin Gülmezoglu A (2005) Systematic Review: WHO systematic review of maternal mortality and morbidity: the prevalence of uterine rupture. BJOG 112:1221–1228

    Article  PubMed  Google Scholar 

  14. Guise JM (2004) Systematic review of the incidence and consequences of uterine rupture in women with previous caesarean section. BMJ 329:19–25

    Article  PubMed  Google Scholar 

  15. Farinelli CK, Hameed AB (2012) Cardiopulmonary resuscitation in pregnancy. Cardiol Clin 30:453–461

    Article  PubMed  Google Scholar 

  16. Mercier FJ, Van de Velde M (2008) Major obstetric hemorrhage. Anesthesiol Clin 26:53–66

    Article  PubMed  Google Scholar 

  17. Khan KS, Wojdyla D, Say L et al (2006) WHO analysis of causes of maternal death: a systematic review. Lancet 367:1066–1074

    Article  PubMed  Google Scholar 

  18. Wen SW, Huang L, Liston R et al (2005) Severe maternal morbidity in Canada, 1991–2001. CMAJ 173:759–764

    PubMed  Google Scholar 

  19. Waterstone M, Bewley S, Wolfe C (2001) Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 322:1089–1093

    Article  PubMed  CAS  Google Scholar 

  20. Hogan MC, Foreman KJ, Naghavi M et al (2010) Maternal mortality for 181 countries, 1980–2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 375:1609–1623

    Article  PubMed  Google Scholar 

  21. Creanga AA, Berg CJ, Syverson C et al (2012) Race, ethnicity, and nativity differentials in pregnancy-related mortality in the United States: 1993–2006. Obstet Gynecol 120:261–268

    Article  PubMed  Google Scholar 

  22. Lutomski JE, Byrne BM, Devane D et al (2012) Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. BJOG 119:306–314

    Article  PubMed  CAS  Google Scholar 

  23. Bateman BT, Berman MF, Riley LE et al (2010) The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg 110:1368–1373

    Article  PubMed  Google Scholar 

  24. Berg CJ, Callaghan WM, Syverson C et al (2010) Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 116:1302–1309

    Article  PubMed  Google Scholar 

  25. Schutte JM, Steegers EAP, Schuitemaker NWE et al (2010) Rise in maternal mortality in the Netherlands. BJOG 117:399–406

    Article  PubMed  CAS  Google Scholar 

  26. Rath W, Surbek D, Kainer F, et al (2008) [Diagnosis and Therapy of Peripartum Hemorrhage]. Leitlinie der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). Available at: http://www.dggg.de/fileadmin/public_docs/Leitlinien/3-3-5-peripartale-blutungen-2010.pdf. Accessed October 2012

  27. Gayat E, Resche-Rigon M, Morel O et al (2011) Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med 37:1816–1825

    Article  PubMed  Google Scholar 

  28. Naef 3rd RW, Chauhan SP, Chevalier SP et al (1994) Prediction of hemorrhage at cesarean delivery. Obstet Gynecol 83:923–926

    Article  PubMed  Google Scholar 

  29. Prata N, Hamza S, Bell S et al (2011) Inability to predict postpartum hemorrhage: insights from Egyptian intervention data. BMC Pregnancy Childbirth 11:97

    Article  PubMed  Google Scholar 

  30. Begley CM, Gyte GML, Devane D, et al (2011) Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev CD007412

    Google Scholar 

  31. Leduc D, Senikas V, Lalonde AB et al (2009) Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can 31:980–993

    PubMed  Google Scholar 

  32. Rogers J, Wood J, McCandlish R et al (1998) Active versus expectant management of third stage of labour: the Hinchingbrooke randomised controlled trial. Lancet 351:693–699

    Article  PubMed  CAS  Google Scholar 

  33. B-Lynch C, Keith LG, Lalonde AB, Karoshi M (2006) A Textbook of Postpartum Hemorrhage: A Comprehensive Guide to Evaluation, Management and Surgical Intervention. Sapiens Publishing, Duncow

    Google Scholar 

  34. Leong BSH, Chua GSW (2011) Quality of resuscitation in hospitals. Singapore Med J 52:616–619

    PubMed  CAS  Google Scholar 

  35. Drife J (1997) Management of primary postpartum haemorrhage. BJOG 104:275–277

    Article  CAS  Google Scholar 

  36. Sihler KC, Napolitano LM (2010) Complications of massive transfusion. Chest 137:209–220

    Article  PubMed  Google Scholar 

  37. Crofts JF, Ellis D, Draycott TJ et al (2007) Change in knowledge of midwives and obstetricians following obstetric emergency training: a randomised controlled trial of local hospital, simulation centre and teamwork training. BJOG 114:1534–1541

    Article  PubMed  CAS  Google Scholar 

  38. Merién AER, van de Ven J, Mol BW et al (2010) Multidisciplinary team training in a simulation setting for acute obstetric emergencies: a systematic review. Obstet Gynecol 115:1021–1031

    Article  PubMed  Google Scholar 

  39. Rizvi F, Mackey R, Barrett T et al (2004) Successful reduction of massive postpartum haemorrhage by use of guidelines and staff education. BJOG 111:495–498

    Article  PubMed  Google Scholar 

  40. Siassakos D, Crofts JF, Winter C et al (2009) The active components of effective training in obstetric emergencies. BJOG 116:1028–1032

    Article  PubMed  CAS  Google Scholar 

  41. Su LL, Chong YS (2012) Massive obstetric haemorrhage with disseminated intravascular coagulopathy. Best Pract Res Clin Obstet Gynaecol 26:77–90

    Article  PubMed  Google Scholar 

  42. Vercauteren M, Palit S, Soetens F et al (2009) Anaesthesiological considerations on tocolytic and uterotonic therapy in obstetrics. Acta Anaesthesiol Scand 53:701–709

    Article  PubMed  CAS  Google Scholar 

  43. Magalhaes JKRS, Carvalho JCA, Parkes RK et al (2009) Oxytocin pretreatment decreases oxytocin-induced myometrial contractions in pregnant rats in a concentration-dependent but not time-dependent manner. Reprod Sci 16:501–508

    Article  PubMed  CAS  Google Scholar 

  44. Dyer RA, Butwick AJ, Carvalho B (2011) Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist. Curr Opin Anaesthesiol 24:255–261

    Article  PubMed  Google Scholar 

  45. Gogarten W, Van Aken H, Kessler P et al (2009) Durchfuehrung von Analgesie- und Anaesthesieverfahren in der Geburtshilfe. 2. Überarbeitete Empfehlungen der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin. Anaesth Intensivmed 50:S502–S507

    Google Scholar 

  46. Thomas TA, Cooper GM (2002) Maternal deaths from anaesthesia: An extract from Why mothers die 1997–1999, the Confidential Enquiries into Maternal Deaths in the United Kingdom. Br J Anaesth 89:499–508

    PubMed  CAS  Google Scholar 

  47. Langesæter E, Rosseland LA, Stubhaug A (2011) Haemodynamic effects of oxytocin in women with severe preeclampsia. Int J Obstet Anesth 20:26–29

    Article  PubMed  Google Scholar 

  48. Sweeney G, Holbrook AM, Levine M et al (1990) Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, in nonpregnant women. Curr Therapeutic Res 47:528–540

    CAS  Google Scholar 

  49. Rydén G, Sjöholm I (1969) Half-life of oxytocin in blood of pregnant and non-pregnant women. Acta Endocrinol 61:425–431

    PubMed  Google Scholar 

  50. Su LL, Chong YS, Samuel M (2012) Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev CD005457

    Google Scholar 

  51. Gohil JT, Tripathi B (2011) A study to compare the efficacy of misoprostol, oxytocin, methyl-ergometrine and ergometrine-oxytocin in reducing blood loss in active management of 3rd stage of labor. J Obstet Gynaecol India 61:408–412

    Article  PubMed  CAS  Google Scholar 

  52. Gibbins KJ, Albright CM, Rouse DJ (2012) Postpartum hemorrhage in the developed world: whither misoprostol? Am J Obstet Gynecol (in press)

    Google Scholar 

  53. Borgman MA, Spinella PC, Perkins JG et al (2007) The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 63:805–813

    Article  PubMed  Google Scholar 

  54. Cotton BA, Au BK, Nunez TC et al (2009) Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma Acute Care Surg 66:41–49

    Article  Google Scholar 

  55. Onwuemene O, Green D, Keith L (2012) Postpartum hemorrhage management in 2012: Predicting the future. Int J Gynecol Obst 119:3–5

    Article  Google Scholar 

  56. Pacheco LD, Saade GR, Gei AF et al (2011) Cutting-edge advances in the medical management of obstetrical hemorrhage. Am J Obstet Gynecol 205:526–532

    Article  PubMed  Google Scholar 

  57. Gutierrez MC, Goodnough LT, Druzin M et al (2012) Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center: a retrospective study. Int J Obstet Anesth 21:230–235

    Article  PubMed  CAS  Google Scholar 

  58. Snegovskikh D, Clebone A, Norwitz E (2011) Anesthetic management of patients with placenta accreta and resuscitation strategies for associated massive hemorrhage. Curr Opin Anaesthesiol 24:274–281

    Article  PubMed  Google Scholar 

  59. Callum JL, Rizoli S (2012) Plasma transfusion for patients with severe hemorrhage: what is the evidence? Transfusion 52(Suppl 1):30S–37S

    Article  PubMed  Google Scholar 

  60. Gogarten W (2011) Postpartum hemorrhage-an update. Anasthesiol Intensivmed Notfallmed Schmerzther 46:508–514

    Article  PubMed  Google Scholar 

  61. Cerneca F, Ricci G, Simeone R et al (1997) Coagulation and fibrinolysis changes in normal pregnancy: Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 73:31–36

    Article  PubMed  CAS  Google Scholar 

  62. Macphail S, Talks K (2004) Massive post-partum haemorrhage and management of disseminated intravascular coagulation. Curr Opin Obstet Gynecol 14:123–131

    Article  Google Scholar 

  63. Pötzsch B, Ivaskevicius V (2011) Haemostasis management of massive bleeding. Hämostaseologie 31:15–20

    Article  PubMed  Google Scholar 

  64. Rugeri L, Levrat A, David JS et al (2007) Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 5:289–295

    Article  PubMed  CAS  Google Scholar 

  65. Brenner B (2004) Haemostatic changes in pregnancy. Thromb Res 114:409–414

    Article  PubMed  CAS  Google Scholar 

  66. Epiney M, Boehlen F, Boulvain M et al (2005) D-dimer levels during delivery and the postpartum. J Thromb Haemost 3:268–271

    Article  PubMed  CAS  Google Scholar 

  67. Shakur H, Roberts I, Bautista R et al (2010) CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376:23–32

    Article  PubMed  CAS  Google Scholar 

  68. Ker K, Edwards P, Perel P, Shakur H, Roberts I (2012) Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 344:e3054

    Article  PubMed  Google Scholar 

  69. Rossaint R, Bouillon B, Cerny V et al (2010) Management of bleeding following major trauma: an updated European guideline. Crit Care 14:R52

    Article  PubMed  Google Scholar 

  70. Novikova N, Hofmeyr GJ (2007) Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev CD007872

    Google Scholar 

  71. Gungorduk K, Yıldırım G, Asıcıoğlu O et al (2011) Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. Am J Perinatol 28:233–240

    Article  PubMed  Google Scholar 

  72. Movafegh A, Eslamian L, Dorabadi A (2011) Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery. BJOG 115:224–226

    CAS  Google Scholar 

  73. Ferrer P, Roberts I, Sydenham E et al (2009) Anti-fibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth 9:29

    Article  PubMed  Google Scholar 

  74. Ducloy-Bouthors A-S, Jude B, Duhamel A et al (2011) High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 15:R117

    Article  PubMed  Google Scholar 

  75. Fergusson DA, Hébert PC, Mazer CD et al (2008) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358:2319–2331

    Article  PubMed  CAS  Google Scholar 

  76. Peitsidis P, Kadir RA (2011) Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother 12:503–516

    Article  PubMed  CAS  Google Scholar 

  77. Lier H, Rath W (2011) Current interdisciplinary recommendations for the management of severe postpartum hemorrhage (PPH). Geburtshilfe und Frauenheilkunde 71:577–588

    Article  Google Scholar 

  78. WHO (2009) WHO Guidelines for the Management of Postpartum Hemorrhage and Retained Placenta. WHO Press, Geneva

    Google Scholar 

  79. Charbit B, Mandelbrot L, Samain E et al (2007) The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 5:266–273

    Article  PubMed  CAS  Google Scholar 

  80. Kratz A, Ferraro M, Sluss PM et al (2004) Laboratory reference values. N Engl J Med 351:1548–1564

    Article  PubMed  CAS  Google Scholar 

  81. Mercier FJ, Bonnet MP (2010) Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage. Curr Opin Anaesthesiol 23:310–316

    Article  PubMed  Google Scholar 

  82. Cortet M, Deneux-Tharaux C, Dupont C et al (2012) Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 108:984–989

    Article  PubMed  CAS  Google Scholar 

  83. Bell SF, Rayment R, Collins PW et al (2010) The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth 19:218–223

    Article  PubMed  CAS  Google Scholar 

  84. Ahonen J, Stefanovic V, Lassila R (2010) Management of post-partum haemorrhage. Acta Anaesthesiol Scand 54:1164–1178

    Article  PubMed  CAS  Google Scholar 

  85. Wood AJJ, Mannucci PM (1998) Hemostatic drugs. N Engl J Med 339:245–253

    Article  Google Scholar 

  86. Lin Y, Stanworth S, Birchall J, et al (2011) Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev CD005011

    Google Scholar 

  87. Ahonen J, Jokela R, Korttila K (2007) An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage. Acta Anaesth Scand 51:929–936

    Article  PubMed  CAS  Google Scholar 

  88. Boehlen F, Morales MA, Fontana P et al (2004) Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature. BJOG 111:284–287

    Article  PubMed  Google Scholar 

  89. Segal S, Shemesh IY, Blumental R et al (2004) The use of recombinant factor VIIa in severe postpartum hemorrhage. Acta Obstet Gynecol Scand 83:771–772

    PubMed  Google Scholar 

  90. Bundesärztekammer, [German Medical Association] (2009) Cross-sectional guidelines for therapy with blood components and plasma derivatives. Available at: https://www.iakh.de/tl_files/iakh/public/richtlinien/Querschnittsleitlinie_4._Auflage_-_englisch_05.01.2011%20copy.pdf. Accessed October 2012

  91. McLintock C, James AH (2011) Obstetric hemorrhage. J Thromb Haemost 9:1441–1451

    Article  PubMed  CAS  Google Scholar 

  92. Van De Velde M (2008) Massive obstetric hemorrhage due to abnormal placentation: uterotonic drugs, cell salvage and activated recombinant factor seven. Acta Anaesthesiol Belg 59:197–200

    Google Scholar 

  93. Welsh A, Mclintock C, Gatt S et al (2008) Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust NZ J Obstet Gynaecol 48:12–16

    Article  Google Scholar 

  94. Vincent JL, Rossaint R, Riou B et al (2006) Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective. Crit Care 10:R120

    Article  PubMed  Google Scholar 

  95. Teig M, Harkness M, Catling S et al (2007) Survey of cell salvage use in obstetrics in the UK. Int J Obstet Anesth 16(Suppl 1):30

    Google Scholar 

  96. Tevet A, Grisaru-Granovsky S, Samueloff A et al (2012) Peripartum use of cell salvage: a university practice audit and literature review. Arch Gynecol Obstet 285:281–284

    Article  PubMed  Google Scholar 

  97. Allam J, Cox M, Yentis SM (2008) Cell salvage in obstetrics. Int J Obstet Anesth 17:37–45

    Article  PubMed  CAS  Google Scholar 

  98. Huissoud C, Carrabin N, Audibert F et al (2009) Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 116:1097–1102

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. Kiefer .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kiefer, N., Weber, S. (2013). Postpartum Hemorrhage. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2013. Annual Update in Intensive Care and Emergency Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35109-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-35109-9_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-35108-2

  • Online ISBN: 978-3-642-35109-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics